Skip to main content
Premium Trial:

Request an Annual Quote

Inivata Raises $6.6M to Develop ctDNA Assays

NEW YORK (GenomeWeb) — Inivata, a Cancer Research UK spinout, has launched with £4 million ($6.6 million) to support its efforts to develop blood tests measuring circulating tumor DNA.

The funding round was led by Imperial Innovations and included Cambridge Innovation Capital and Johnson & Johnson Development Corporation.

Inivata will develop ctDNA assays using tagged-amplicon sequencing, or TAm-Seq, technology, licensed from Cancer Research Technology and the University of Cambridge where it was originally developed at the lab of Nitzan Rosenfeld, who is CSO of the new company.

TAm-Seq is one of a growing crowd of "liquid biopsy" approaches, which aim to analyze circulating cell-free DNA in a patient's blood for the presence of potentially informative or actionable tumor mutations.

Inivata said it is now focused on working with industry and academics to develop new clinical applications for ctDNA analysis. The goal is to be able to use ctDNA to provide physicians with information they can use to personalize treatment for their patients, improve outcomes, and design more effective clinical trials.

"There is major focus on ctDNA analysis which promises the ability to improve monitoring and treatment of cancer based on information from routine blood samples," Inivata CEO Michael Stocum said in a statement. "We are taking a collaborative approach to the development of clinical applications for ctDNA analysis which have the potential to transform how the disease is understood and treated."

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.